Why Fast-paced Mover Xperi (XPER) Is a Great Choice for Value Investors

The article advocates for a momentum investing strategy that combines recent price acceleration with attractive valuations, contrasting it with traditional pure momentum plays that can lead to overvalued assets. Xperi (XPER) is highlighted as a prime example, exhibiting significant recent price momentum—up 4.3% in four weeks and 14.8% in 12 weeks, with a beta of 1.54—and a favorable Zacks Rank #1. Crucially, XPER maintains a low Price-to-Sales ratio of 0.86, indicating it is trading at a bargain valuation despite its strong momentum, suggesting considerable upside potential for investors.

Analysis

Xperi (XPER) is presented as a compelling investment based on a 'momentum at a bargain' strategy, which seeks to mitigate the risks of overvaluation common in pure momentum plays. The stock's positive momentum is substantiated by its recent price performance, showing a 4.3% gain over the past four weeks and a 14.8% increase over the last twelve. This movement is characterized as 'fast-paced' by a high beta of 1.54, indicating the stock's price is expected to move 54% more than the broader market. This technical strength is supported by fundamental signals, notably a Zacks Rank #1 (Strong Buy) designation, which the report attributes to a trend of upward earnings estimate revisions from covering analysts. Crucially, despite this strong performance and positive analyst sentiment, XPER is described as attractively valued. Its current Price-to-Sales (P/S) ratio stands at 0.86, suggesting investors pay only 86 cents for each dollar of sales, which is positioned as a significant discount and implies substantial room for further price appreciation.

Key Decisions for Investors

• For portfolios with a growth and momentum mandate, XPER presents a potential long opportunity, supported by its Zacks #1 Rank, strong recent price performance, and a compelling Price-to-Sales ratio of 0.86.
• Investors must be prepared for heightened volatility, as the stock's high beta of 1.54 suggests it will experience price swings significantly greater than the overall market, requiring careful risk management and position sizing.
• The investment thesis is heavily reliant on continued positive earnings estimate revisions; traders should monitor analyst rating changes closely, as any reversal in this trend could quickly undermine the stock's momentum.